Pew Urges Reversal of Federal Policies Limiting Diagnostic Test Oversight

Reverse Federal Policies Limiting Diagnostic Test Oversight

The Pew Charitable Trusts sent a letter to Secretary of Health and Human Services Xavier Becerra on April 28 urging the department to rescind policies that could undermine the Food and Drug Administration’s oversight of medical products, including COVID-19 tests. Pew also recommended that the administration work to reform federal regulation of clinical tests to ensure that diagnostic tools meet consistent, high standards for accuracy and reliability, regardless of where the tools are developed and used.

Tests that analyze blood, saliva, and other human samples—known as in vitro diagnostics (IVDs)—help clinicians determine appropriate, effective care for infectious diseases, cancer, and many other serious illnesses. The FDA must have the ability to review and monitor the performance of all IVDs to ensure that patients and their providers can trust the results from these products. But under current policies, tests developed and used in individual laboratories are typically not subject to the agency’s review and reporting requirements. This uneven oversight poses unnecessary risks for both patients and public health, and has allowed unreliable tests to reach the market, leading to incorrect diagnoses and treatment.

Diagnostic Test
Diagnostic Test
Article

Test Regulation Should Rank High on Agenda of Congress

Quick View
Article

Faulty diagnostic tests can compromise both patient care and the nation’s response to infectious diseases—as made all too clear earlier this month when the Food and Drug Administration issued a safety alert about a COVID-19 test that carries a high risk of false negative results.

Getty
Getty Images
Article

Safeguards Are Needed to Curb Unreliable COVID-19 Tests

Quick View
Article

A decision announced Aug. 19 by the federal Department of Health and Human Services (HHS) complicates the already fragmented regulatory system for diagnostics and could let inaccurate COVID-19 tests on the market, potentially undermining efforts to control the disease’s spread.

The front facade of the Supreme Court of the United States in Washington, DC.
ian-hutchinson-U8WfiRpsQ7Y-unsplash.jpg_master

Agenda for America

A collection of resources to help federal, state, and local decision-makers set an achievable agenda for all Americans

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest.

Lightbulbs
Lightbulbs

States of Innovation

Data-driven state policy innovations across America

Quick View

Data-driven policymaking is not just a tool for finding new solutions for difficult challenges. When states serve their traditional role as laboratories of innovation, they increase the American people’s confidence that the government they choose—no matter the size—can be effective, responsive, and in the public interest.